APEIRON Biologics Announces Changes to Management and Supervisory Boards

  • Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO)
  • Prof. Josef Penninger moves from the Supervisory Board to the newly created Scientific Advisory Board, which he will build up and lead as Chairman
  • Additional pre-clinical data show highly promising results with APN01 in various
    mutation variants
  • APEIRON to propose Ulrich Granzer PhD as new member of the Supervisory Board at the upcoming Annual General Meeting

Press release (EN) | Presseaussendung (DE)